Secondly, some other molecular markers (TP53, RB1) have also been reported and confirmed to be related to cancer recurrence, so it may be necessary to expand the screening of target proteins and explore new immunohistochemical or molecular markers to further improve the predictive ability of the model in future studies [3,8,28]. Here, RB1 is linked to cancer.